Visit iDataResearch.com
  Monthly Medtech Newsletter
  September 2018
 
Feature Story:

Boston Scientific Announces Agreement To Acquire Augmenix, Inc.

Boston Scientific announced that it has entered into a definitive agreement to acquire Augmenix, Inc., a privately-held company which has developed and commercialized the SpaceOAR® System, a therapy used to reduce common and debilitating side effects that men may experience after receiving prostate cancer radiotherapy. The transaction consists of an upfront cash payment of $500 million, and up to $100 million for reaching sales-based milestones. Each year, more than 1.1 million men are diagnosed with prostate cancer worldwide and approximately 400,000 men will undergo prostate radiotherapy. One of the most common complications of treatment is...

Click here to read more

An Astounding 19 Million Colonoscopies are Performed Annually in The United States

An analysis of endoscopic gastro-intestinal procedure volumes by iData Research shows that over 19 million colonoscopies are performed annually, as reported in 2017, a significant contribution to the 75 million endoscopies performed each year in the United States. A major factor driving growth in colonoscopy procedures is the increasing public awareness of colon cancer, through media campaigns initiated by cancer awareness groups and government bodies, as well as an aging population that is recommended to receive regular screenings. The U.S. screening program, in particular, has been...

read more}

 

Bayer to Voluntarily Discontinue U.S. Sales of Essure at End of 2018

Bayer has made a business decision to voluntarily discontinue sales and distribution of the Essure® System for Permanent Birth Control in the United States after December 31, 2018. This decision is based on a decline in U.S. sales of Essure in recent years and the conclusion that the Essure business is no longer sustainable. Essure is the only FDA-approved non-incisional form of permanent birth control. The benefit-risk profile of Essure has not changed, and we continue to stand behind the product’s safety and efficacy, which are demonstrated by an extensive body of research, undertaken by Bayer and independent medical researchers, involving more than 200,000...

read more}

 

Abbott’s FreeStyle® Libre 14 Day Flash Glucose Monitoring System Now Approved in the U.S.

According to a recent press release from Abbott, “the U.S. Food and Drug Administration (FDA) has approved the FreeStyle® Libre 14 day Flash Glucose Monitoring system, which allows people with diabetes to wear the sensor up to 14 days with high accuracy. This approval makes Abbott’s revolutionary continuous glucose monitor (CGM) the longest lasting self-applied personal glucose sensor available on the market.” Here’s what our analysts have to say about this new update in the U.S. diabetes market: After leaving the continuous glucose monitoring (CGM) market in 2011, when it discontinued its FreeStyle Navigator product line, Abbott re-entered the market in 2016 with...

read more}

 

Over 75 Million CT Scans Are Performed Each Year and Growing Despite Radiation Concerns

According to the latest results from iData Research’s medical imaging procedures analysis, over 75 million CT scans are performed each year in the United States. This number is forecasted to grow to reach 84 million procedures by 2022, despite the significant concerns about radiation exposure. The majority of CT scan procedures performed are for diagnostic purposes, particularly for the head, neck and facial regions. In recent years, there has been a surge in popularity for CT scanner usage in cardiac procedures, most notably cardiac CT angiography. These scans require premium systems with higher image resolutions. Higher-resolution systems, as expected, are...

read more}

 

Inspire Medical Systems, Inc. Announces Aetna Coverage for Inspire Therapy for the Treatment of Obstructive Sleep Apnea

Inspire Medical Systems, Inc. (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea (OSA), announced that Aetna Inc., one of the leading health plans in the United States, will provide coverage for the Company’s Inspire therapy, effective immediately. Aetna’s plan provides coverage for approximately 22 million members. “We are very pleased to receive this positive coverage decision from Aetna. We believe this coverage decision is a major milestone and has the potential to...

read more}

 

Dysis Medical Raises $25M

Dysis Medical said it raised $25 million (GBP £18 million) in a new round to help support its Dysis colposcope used for cervical cancer screenings. The Dysis colposcope uses both optical imaging and software to scan the cervix to improve cervical cancer screening procedures, the company said. Funds in the round will help support expansion into the US, across the U.K. and in “other key territories,” the Edinburgh, Scotland-based company said. Funds may also be used to support strategic R&D. “We are excited to support the rapid growth of Dysis Medical and the advancement of the Dysis colposcope. We recognize the momentum the company is achieving globally and we are...

read more}

 
 
 
  Browse Report Categories  
 

Anesthesiology

Cosmetic Surgery

Diagnostics

Dialysis

Endoscopy

Gastrointestinal

Hearing Devices

Laparoscopy

Neurology

Oncology

Ophthalmics

Patient Monitoring

Pharmaceuticals

Soft Tissue Reinforcement and Regeneration

Ultrasound Imaging

Urology

Video Hi-Tech Navigation & Robotics

Women's Health

Wound & Tissue Care

BROWSE ALL

 
 
 

Latest Publications

 
 

Taiwan Market Report Suite For Spinal Implants and VCF Devices 2018 - MedSuite

Taiwan Market Report Suite For Minimally Invasive Spinal Implants 2018 - MedSuite

Japan Market Report Suite for Spinal Implants and VCF 2018 - MedSuite

Europe Market Report Suite For Digital Dentistry 2018 - MedSuite

Europe Market Report Suite For Cardiac Surgery Devices 2018 - MedSuite

Brazil Market Report Suite for Dental Prosthetics 2018 – MedSuite

US Market Report Suite for Overdentures and Implant Bridges 2018 – MedSuite

Europe Market Report Suite For Soft Tissue Reinforcement And Regeneration 2018 - MedSuite

US Market Report Suite for Video and Integrated Operating Room Equipment 2018 – MedSuite

US Market Report Suite for Vascular Access Devices and Accessories 2018 – MedSuite

US Market Report Suite for Infusion Therapy Devices 2018 – MedSuite

US Market Report Suite For Cardiac Surgery And Heart Valve Devices 2018 - MedSuite

US Market Report Suite For Interventional Cardiology Devices 2018 - MedSuite

 
  View More  
   
 
 
 
 

Upcoming Publications

 
 

Europe Market Report Suite for Anesthesia, Respiratory and Sleep Management Devices 2018 - MedSuite

South Korea Market Report Suite for Dental Bone Graft Substitutes and Other Biomaterials 2018 - MedSuite

Mexico Market Report Suite For Dental Prosthetics 2018 - MedSuite

Australia Market Report Suite For Spinal Implants and VCF Devices 2018 - MedSuite

Europe Market Report Suite for Dental Prosthetics 2018 – MedSuite

Mexico Market Report Suite for Dental Prosthetics 2018 – MedSuite

Argentina Market Report Suite for Dental Prosthetics 2018 – MedSuite

 
  View More  
     
 
 
 
Search All iData Report Categories
 
  WEBSITE | ABOUT | Blog | CONTACT | STAY CONNECTED facebook twitter linkedin  
 

iData Research | 308 - 4211 Kingsway, Burnaby BC, V5H 1Z6 | Tel: 604-266-6933 | info@idataresearch.net

Click here to unsubscribe from the iData Monthly Newsletter